ReShape Lifesciences (RSLS) Competitors $0.36 -0.03 (-6.82%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$0.87 +0.51 (+140.50%) As of 08:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock RSLS vs. ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, and DXCMShould you be buying ReShape Lifesciences stock or one of its competitors? The main competitors of ReShape Lifesciences include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "health care equipment" industry. ReShape Lifesciences vs. Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom Abbott Laboratories (NYSE:ABT) and ReShape Lifesciences (NASDAQ:RSLS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking. Which has higher earnings & valuation, ABT or RSLS? Abbott Laboratories has higher revenue and earnings than ReShape Lifesciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.95B5.49$13.40B$7.6517.35ReShape Lifesciences$8.18M0.15-$11.39MN/AN/A Which has more risk & volatility, ABT or RSLS? Abbott Laboratories has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Is ABT or RSLS more profitable? Abbott Laboratories has a net margin of 31.95% compared to ReShape Lifesciences' net margin of -86.36%. Abbott Laboratories' return on equity of 20.74% beat ReShape Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories31.95% 20.74% 11.19% ReShape Lifesciences -86.36%-179.83%-91.48% Does the media prefer ABT or RSLS? In the previous week, Abbott Laboratories had 67 more articles in the media than ReShape Lifesciences. MarketBeat recorded 69 mentions for Abbott Laboratories and 2 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.43 beat Abbott Laboratories' score of 1.28 indicating that ReShape Lifesciences is being referred to more favorably in the news media. Company Overall Sentiment Abbott Laboratories Positive ReShape Lifesciences Positive Do analysts rate ABT or RSLS? Abbott Laboratories currently has a consensus price target of $137.94, suggesting a potential upside of 3.90%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities analysts clearly believe Abbott Laboratories is more favorable than ReShape Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.84ReShape Lifesciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer ABT or RSLS? Abbott Laboratories received 548 more outperform votes than ReShape Lifesciences when rated by MarketBeat users. Likewise, 69.97% of users gave Abbott Laboratories an outperform vote while only 66.11% of users gave ReShape Lifesciences an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes94669.97% Underperform Votes40630.03% ReShape LifesciencesOutperform Votes39866.11% Underperform Votes20433.89% Do institutionals & insiders have more ownership in ABT or RSLS? 75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryAbbott Laboratories beats ReShape Lifesciences on 15 of the 17 factors compared between the two stocks. Remove Ads Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RSLS vs. The Competition Export to ExcelMetricReShape LifesciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19M$6.89B$5.63B$7.79BDividend YieldN/A2.81%5.37%4.04%P/E RatioN/A7.4223.6118.68Price / Sales0.15207.04373.3989.80Price / CashN/A65.6738.1734.64Price / Book0.016.206.734.12Net Income-$11.39M$142.11M$3.20B$247.10M7 Day Performance-31.06%-7.28%-5.33%-3.82%1 Month Performance-65.00%-10.45%-0.40%-6.61%1 Year Performance-96.18%-12.86%7.89%-1.67% ReShape Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RSLSReShape Lifesciences0.8665 of 5 stars$0.36-6.8%N/A-96.6%$1.19M$8.18M0.0050Short Interest ↓ABTAbbott Laboratories4.9032 of 5 stars$127.31+0.8%$137.94+8.4%+16.8%$220.79B$41.95B16.64115,000Positive NewsISRGIntuitive Surgical4.6075 of 5 stars$508.58+3.3%$611.86+20.3%+24.1%$181.15B$8.35B79.3412,100Positive NewsGap UpBSXBoston Scientific4.232 of 5 stars$102.74+2.0%$108.91+6.0%+47.4%$151.96B$16.75B82.1945,000Positive NewsSYKStryker4.7691 of 5 stars$374.43+0.9%$421.90+12.7%+4.2%$142.87B$22.60B48.2553,000Positive NewsMDTMedtronic4.3626 of 5 stars$90.16-0.2%$96.07+6.6%+3.2%$115.64B$33.20B27.4095,000Positive NewsBDXBecton, Dickinson and Company4.7493 of 5 stars$229.10-0.5%$278.29+21.5%-7.3%$65.78B$20.64B38.0674,000Positive NewsEWEdwards Lifesciences4.6266 of 5 stars$71.43+1.4%$79.95+11.9%-24.1%$41.99B$5.44B10.2517,300Positive NewsIDXXIDEXX Laboratories4.2536 of 5 stars$423.60+0.6%$533.75+26.0%-22.2%$34.34B$3.90B39.7010,800Positive NewsRMDResMed4.5205 of 5 stars$222.95+1.5%$246.83+10.7%+13.0%$32.74B$4.93B26.328,160Positive NewsDXCMDexCom4.8997 of 5 stars$75.32+2.1%$99.82+32.5%-50.8%$29.43B$4.03B52.677,600Positive News Remove Ads Related Companies and Tools Related Companies ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives BDX Alternatives EW Alternatives IDXX Alternatives RMD Alternatives DXCM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RSLS) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
